# Flora Zagouri

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/flora-zagouri/

## Facts

| Field | Value |
| --- | --- |
| Citations | 10,804 |
| Field | Breast Cancer Treatment Studies |
| h-index | 46 |
| i10-index | 200 |
| Last Known Institution | National and Kapodistrian University of Athens |
| OpenAlex ID | https://openalex.org/A5046758725 |
| ORCID iD | 0000-0001-7153-6556 |
| Works | 516 |

## Researcher papers

- [Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer](https://scholariq.org/papers/trastuzumab-deruxtecan-in-previously-treated-her2-low-advanced-breast-cancer/)
- [Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial](https://scholariq.org/papers/pembrolizumab-or-placebo-with-chemoradiotherapy-followed-by-pembrolizumab-or/)
- [Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/trastuzumab-deruxtecan-versus-treatment-of-physician-s-choice-in-patients-with/)
- [Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting](https://scholariq.org/papers/gynecologic-cancers-in-pregnancy-guidelines-based-on-a-third-international/)
- [Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/pembrolizumab-or-placebo-with-chemoradiotherapy-followed-by-pembrolizumab-or-2/)
- [Trastuzumab administration during pregnancy: a systematic review and meta-analysis](https://scholariq.org/papers/trastuzumab-administration-during-pregnancy-a-systematic-review-and-meta/)
- [Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis](https://scholariq.org/papers/intrathecal-administration-of-trastuzumab-for-the-treatment-of-meningeal/)
- [Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement](https://scholariq.org/papers/utility-of-prognostic-genomic-tests-in-breast-cancer-practice-the-impakt-2012/)
- [Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study](https://scholariq.org/papers/adjuvant-abemaciclib-combined-with-endocrine-therapy-for-high-risk-early-breast-2/)
- [Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease](https://scholariq.org/papers/circulating-levels-of-matrix-metalloproteinase-9-mmp-9-neutrophil-gelatinase/)
- [Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial](https://scholariq.org/papers/patient-reported-outcomes-and-qualitative-interviews-in-patients-with-estrogen/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Researcher university

- [National and Kapodistrian University of Athens](https://scholariq.org/institutions/national-and-kapodistrian-university-of-athens/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.